Literature DB >> 12414509

Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.

Yasuhito Hamaguchi1, Yoriko Nishizawa, Masahide Yasui, Minoru Hasegawa, Yuko Kaburagi, Kazuhiro Komura, Tetsuya Nagaoka, Eriko Saito, Yuka Shimada, Kazuhiko Takehara, Takafumi Kadono, Douglas A Steeber, Thomas F Tedder, Shinichi Sato.   

Abstract

The development of bleomycin-induced lung injury, a model of pulmonary fibrosis, results from inflammatory cell infiltration, a process highly regulated by the expression of multiple adhesion molecules. At present, the identity and role of the adhesion molecules involved in the fibrotic process are unknown. Therefore, bleomycin-induced pulmonary fibrosis was examined in mice lacking L-selectin (L-selectin(-/-)) expression, intercellular adhesion molecule-1 (ICAM-1) expression, or both. After 16 days of intratracheal bleomycin challenge, collagen deposition was inhibited in both L-selectin(-/-) and ICAM-1(-/-) mice when compared with wild-type littermates. Interestingly, collagen deposition was virtually eliminated in L-selectin/ICAM-1(-/-) mice relative to either the L-selectin(-/-) or ICAM-1(-/-) mice. Decreased pulmonary fibrosis was associated with reduced accumulation of leukocytes, including neutrophils and lymphocytes. Decreased mRNA expression of proinflammatory cytokines and transforming growth factor (TGF)-beta1 paralleled the inhibition of collagen deposition. The present study indicates that L-selectin and ICAM-1 play a critical role in pulmonary fibrosis by mediating the accumulation of leukocytes, which regulate the production of proinflammatory cytokines and TGF-beta1. This suggests that these adhesion molecules are potential therapeutic targets for inhibiting human pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414509      PMCID: PMC1850777          DOI: 10.1016/S0002-9440(10)64439-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury.

Authors:  T Matsuse; S Teramoto; H Katayama; E Sudo; H Ekimoto; H Mitsuhashi; Y Uejima; Y Fukuchi; Y Ouchi
Journal:  Eur Respir J       Date:  1999-01       Impact factor: 16.671

2.  Role of E-selectin in bleomycin induced lung fibrosis in mice.

Authors:  A Azuma; S Takahashi; M Nose; K Araki; M Araki; T Takahashi; M Hirose; H Kawashima; M Miyasaka; S Kudoh
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Effect of antibody against integrin alpha4 on bleomycin-induced pulmonary fibrosis in mice.

Authors:  Q Wang; Y Wang; D M Hyde; P J Gotwals; R R Lobb; S T Ryan; S N Giri
Journal:  Biochem Pharmacol       Date:  2000-12-15       Impact factor: 5.858

4.  L-selectin and intercellular adhesion molecule 1 mediate lymphocyte migration to the inflamed airway/lung during an allergic inflammatory response in an animal model of asthma.

Authors:  E Keramidaris; T D Merson; D A Steeber; T F Tedder; M L Tang
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

5.  L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma.

Authors:  L C Fiscus; J Van Herpen; D A Steeber; T F Tedder; M L Tang
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

6.  Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression.

Authors:  T Nagaoka; Y Kaburagi; Y Hamaguchi; M Hasegawa; K Takehara; D A Steeber; T F Tedder; S Sato
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice.

Authors:  I Gur; R Or; M J Segel; M Shriki; G Izbicki; R Breuer
Journal:  Exp Lung Res       Date:  2000 Oct-Nov       Impact factor: 2.459

8.  GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism.

Authors:  B B Moore; M J Coffey; P Christensen; S Sitterding; R Ngan; C A Wilke; R McDonald; S M Phare; M Peters-Golden; R Paine; G B Toews
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

9.  Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis.

Authors:  J G Clark; C Kuhn
Journal:  Am Rev Respir Dis       Date:  1982-10

10.  Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions.

Authors:  O Spertini; F W Luscinskas; M A Gimbrone; T F Tedder
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  17 in total

1.  ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.

Authors:  Pelagia G Tsoutsou; Konstantinos I Gourgoulianis; Efthymia Petinaki; Maria Mpaka; Smaragda Efremidou; Antonios Maniatis; Pashalis Adam Molyvdas
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

2.  Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury.

Authors:  Min He; Ni Cheng; Wei-wei Gao; Meng Zhang; Yue-yun Zhang; Richard D Ye; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

3.  Regulation of local and metastatic host-mediated anti-tumour mechanisms by L-selectin and intercellular adhesion molecule-1.

Authors:  M Yamada; K Yanaba; M Hasegawa; Y Matsushita; M Horikawa; K Komura; T Matsushita; A Kawasuji; T Fujita; K Takehara; D A Steeber; T F Tedder; S Sato
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.

Authors:  Ayumi Yoshizaki; Koichi Yanaba; Yohei Iwata; Kazuhiro Komura; Asako Ogawa; Yuichiro Akiyama; Eiji Muroi; Toshihide Hara; Fumihide Ogawa; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

5.  Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells.

Authors:  Yulin Jia; Jun Jia; Yifang Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

6.  E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.

Authors:  Mayuka Horikawa; Manabu Fujimoto; Minoru Hasegawa; Takashi Matsushita; Yasuhito Hamaguchi; Ayako Kawasuji; Yukiyo Matsushita; Tomoyuki Fujita; Fumihide Ogawa; Kazuhiko Takehara; Douglas A Steeber; Shinichi Sato
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

7.  Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.

Authors:  Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum
Journal:  J Pharmacol Exp Ther       Date:  2020-11-02       Impact factor: 4.030

8.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

9.  An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice.

Authors:  Daniel Voskas; Yael Babichev; Ling S Ling; Jennifer Alami; Yuval Shaked; Robert S Kerbel; Brian Ciruna; Daniel J Dumont
Journal:  J Leukoc Biol       Date:  2008-05-01       Impact factor: 4.962

10.  Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.

Authors:  Yuichi Shimaoka; Shunji Tajima; Fumio Fujimori; Cristiane Yamabayashi; Hiroshi Moriyama; Masaki Terada; Toshinori Takada; Eiichi Suzuki; Masashi Bando; Yukihiko Sugiyama; Ichiei Narita
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.